COMPLEX PATTERN OF THE MYELOMONOCYTIC DIFFERENTIATION ANTIGENS MRP8 AND MRP14 DURING CHRONIC AIRWAY INFLAMMATION

被引:94
作者
ROTH, J [1 ]
TEIGELKAMP, S [1 ]
WILKE, M [1 ]
GRUN, L [1 ]
TUMMLER, B [1 ]
SORG, C [1 ]
机构
[1] HANNOVER MED SCH, DEPT BIOPHYS CHEM OE 4350, W-3000 HANNOVER 61, GERMANY
关键词
D O I
10.1016/S0171-2985(11)80259-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
One of the characteristics of cystic fibrosis is the presence of the so-called cystic fibrosis antigen in the plasma of patients. The CF-antigen has been shown to consist of the two calcium-binding proteins MRP8 and MRP14. In the present study we investigate first whether elevated plasma titers of MRP8 and MRP14 are linked to the primary defect of CF or are rather a result of chronic airway inflammation; and second, whether the known complexes of these proteins may have in vivo relevance during inflammation. By employing the ELISA technique we measured MRP8 and MRP14 levels in the plasma of patients suffering from CF or nonspecific chronic bronchitis (CB) and of healthy controls, in sputum of CF and CB patients, and in saliva of CF patients and healthy controls, respectively. We found elevated plasma concentrations of both proteins in CF and CB patients compared to healthy controls. Levels correlated significantly with systemic and local signs of disease activity (i.e. c-reactive protein (CRP), daily sputum production). MRP8 and MRP14 both were found in high amounts at similar concentrations in sputum of CF and CB patients and, to a lesser extent, in saliva of CF patients and healthy donors. After covalent cross-linking at least three different complexes composed of MRP8 and MRP14 with approximate molecular weights of about 25, 35 and 48 kDa were detected in all samples. From this we conclude that the elevated plasma levels of MRP8 and MRP14 in CF and CB are the result of inflammatory processes. Further, possible biological functions of these proteins seem to be associated with complexed forms of MRP8 and MRP14 rather than with individual proteins.
引用
收藏
页码:304 / 314
页数:11
相关论文
共 27 条
[1]   LEUKOCYTE L1 PROTEIN AND THE CYSTIC-FIBROSIS ANTIGEN [J].
ANDERSSON, KB ;
SLETTEN, K ;
BERNTZEN, HB ;
FAGERHOL, MK ;
DALE, I ;
BRANDTZAEG, P ;
JELLUM, E .
NATURE, 1988, 332 (6166) :688-688
[2]   IDENTIFICATION OF CYSTIC-FIBROSIS PROTEIN AS A COMPLEX OF 2 CALCIUM-BINDING PROTEINS PRESENT IN HUMAN-CELLS OF MYELOID ORIGIN [J].
BARTHE, C ;
FIGARELLA, C ;
CARRERE, J ;
GUYCROTTE, O .
BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1096 (02) :175-177
[3]  
BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
[4]   DISTRIBUTION OF A FORMALIN-RESISTANT MYELOMONOCYTIC ANTIGEN (L1) IN HUMAN-TISSUES .1. COMPARISON WITH OTHER LEUKOCYTE MARKERS BY PAIRED IMMUNOFLUORESCENCE AND IMMUNOENZYME STAINING [J].
BRANDTZAEG, P ;
DALE, I ;
FAGERHOL, MK .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1987, 87 (06) :681-699
[5]   THE MOLECULAR NATURE OF THE CYSTIC-FIBROSIS ANTIGEN [J].
BRUGGEN, J ;
TARCSAY, L ;
CERLETTI, N ;
ODINK, K ;
RUTISHAUSER, M ;
HOLLANDER, G ;
SORG, C .
NATURE, 1988, 331 (6157) :570-570
[6]  
BRUGGEN J, 1991, NOVEL CALCIUM BINDIN, P237
[7]   DISTRIBUTION OF A NEW MYELOMONOCYTIC ANTIGEN (L1) IN HUMAN PERIPHERAL-BLOOD LEUKOCYTES - IMMUNOFLUORESCENCE AND IMMUNOPEROXIDASE STAINING FEATURES IN COMPARISON WITH LYSOZYME AND LACTOFERRIN [J].
DALE, I ;
BRANDTZAEG, P ;
FAGERHOL, MK ;
SCOTT, H .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1985, 84 (01) :24-34
[8]   A CLUE TO THE BASIC DEFECT IN CYSTIC-FIBROSIS FROM CLONING THE CF-ANTIGEN GENE [J].
DORIN, JR ;
NOVAK, M ;
HILL, RE ;
BROCK, DJH ;
SECHER, DS ;
VANHEYNINGEN, V .
NATURE, 1987, 326 (6113) :614-617
[9]  
EDGEWORTH J, 1991, J BIOL CHEM, V266, P7706
[10]   EPIDERMAL AND DERMAL DISTRIBUTION OF A MYELOMONOCYTIC ANTIGEN (L1) SHARED BY EPITHELIAL-CELLS IN VARIOUS INFLAMMATORY SKIN DISEASES [J].
GABRIELSEN, TO ;
DALE, I ;
BRANDTZAEG, P ;
HOEL, PS ;
FAGERHOL, MK ;
LARSEN, TE ;
THUNE, PO .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1986, 15 (02) :173-179